Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,678.5
25.5 (0.96%)

 

  • STI Straits Times Index
    2,678.5
    25.5 (0.96%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.6
    18.9 (1.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,248.2
    875.1 (3.45%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,286.6
    133.8 (4.24%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,685.9
    379.5 (1.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,995.2
    21.5 (0.43%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 697.1M
  • Value: 416.4M
  • Rise: 211
  • Fall: 73
  • Unch: 524

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Singapore-eDev0.121+0.006
Medtecs Intl0.580+0.080
Rex Intl0.184+0.004
LionGold0.002-
Synagie0.198+0.007
Yoma Strategic0.320+0.005
MDR0.001-
AnAn Intl0.070+0.006
Spackman0.009-0.001
Adventus0.023+0.002

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

INOVIO PHARMACEUTICALS INC INOVIO PHARMACEUTICALS
Updated on 02 Jul 2020 (End of trading day)
Last (USD): 21.450 Change: +1.720 High: 22.480 Remarks: -
Change (%): +8.72 Low: 19.900
Open 19.910 Yesterday's Close 19.73
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 52,386,860 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.75498 Trailing EPS (USD) e -0.77599 NAV (USD) b 1.1659
PE a - Trailing PE f - Price / NAV b 18.3978
Dividend (USD) d - Cash In Hand (USD) g 1.0022 Issued & Paid-up Shares c 158,096,000
Dividend Yield (%) d - Price / Cash In Hand g 21.403 Treasury Shares h -
Market Cap (M) 3,391.159 Enterprise Value (M) 3,223.212
Piotroski F Score 1 Exchange Code INO Par Value ( $ ) n.a.
52 Weeks Volatility (%) 189.59 Free Float (%) 97.5
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference INOVIO PHARMACEUTICALS INC NASDAQ 3,391.159 - - 18.3978 -
Industry Medical Specialties NASDAQ 2,360.614 404.083 112.330 8.1515 0.038
Local Peer INTUITIVE SURGICAL INC NASDAQ 67,694.417 49.079 48.831 7.9578 -
Local Peer DEXCOM INC NASDAQ 37,598.405 371.894 254.215 40.2337 -
Local Peer IDEXX LABORATORIES INC NASDAQ 28,432.171 66.474 65.082 264.0480 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 22,048.099 49.795 11.671 7.7281 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 21,829.665 67.230 164.819 10.3111 -
Local Peer HOLOGIC INC NASDAQ 14,939.799 - 24.245 7.1616 -
Local Peer INSULET CORPORATION NASDAQ 13,235.049 1,140.920 2,567.918 224.3279 -
Local Peer MASIMO CORPORATION NASDAQ 12,539.620 63.907 59.331 10.0054 -
Local Peer ABIOMED INC NASDAQ 11,884.435 58.541 58.541 11.1542 -
Local Peer DENTSPLY SIRONA INC NASDAQ 9,678.954 36.816 115.501 2.0648 0.857
Local Peer QUIDEL CORP NASDAQ 9,535.453 130.764 107.972 15.7559 -
Local Peer BRUKER CORPORATION NASDAQ 6,400.545 32.457 36.182 6.9905 0.385
Other Local Peers NOVOCURE LTD (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), INARI MEDICAL INC (NASDAQ), ATRICURE INC (NASDAQ), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYNEX INC (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), VIEWRAY INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), MISONIX INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), DERMTECH INC (NASDAQ), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), CELSION CORPORATION (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), NEOVASC INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEURONETICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), ELECTROCORE INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AETHLON MEDICAL INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), ENDOLOGIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), DIGIRAD CORP (NASDAQ), DYNATRONICS CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 163,141.035 44.501 46.098 5.3988 1.426
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 144,508.621 39.099 39.386 5.0600 0.210
Global Peer DANAHER CORP NYSE 127,293.757 51.147 46.508 4.3216 0.372
Global Peer MEDTRONIC PLC NYSE 124,955.508 26.092 26.092 2.4628 2.318
Global Peer BECTON DICKINSON & CO NYSE 69,460.859 64.197 76.331 3.3157 1.199
Global Peer STRYKER CORP NYSE 68,945.862 33.099 31.860 5.2570 1.160
Global Peer BOSTON SCIENTIFIC CORP NYSE 50,548.467 10.755 11.791 3.6619 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,375.588 44.331 43.463 5.7638 0.970
Global Peer EDWARDS LIFESCIENCES CORP NYSE 42,874.552 40.954 38.702 10.9904 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 42,666.250 32.665 32.665 3.0174 1.923
Other Global Peers ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), STERIS PLC (NYSE), HARTA (Bursa), TOPGLOV (Bursa), Top Glove (SGX), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), WEIGAO GROUP (HKEx), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), MICROPORT (HKEx), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), KANGJI MEDICAL (HKEx), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), NEVRO CORP (NYSE), AK MEDICAL (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), SUPERMX (Bursa), PEIJIA-B (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), EBOS GROUP (ASX), CONMED CORP (NYSE), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), KDL MEDICAL (HKEx), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), LIFETECH SCI (HKEx), VAPOTHERM INC (NYSE), CIRC (HKEx), CRYOLIFE INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), YESTAR HEALTH (HKEx), CORMEDIX INC (NYSE American), PW MEDTECH (HKEx), MCP INCOME OPPORTUNITIES TRUST (ASX), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), GOLDEN MEDITECH (HKEx), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ALPHA PRO TECH (NYSE American), INVACARE CORP (NYSE), RETRACTABLE TECHNOLOGIES INC (NYSE American), Medtecs Intl (SGX), UG Healthcare (SGX), MODERN DENTAL (HKEx), VINCENT MED (HKEx), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), VOLITIONRX LIMITED (NYSE American), RESAPP HEALTH LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), YUNNAN ENERGY (HKEx), DAXOR CORP (NYSE American), MILESTONE SCIENTIFIC INC (NYSE American), LKL (Bursa), Biolidics (SGX), SDI LTD (ASX), IMPEDIMED LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DIMERIX LTD (ASX), ONCOCYTE CORP (NYSE American), COMPUMEDICS (ASX), RESONANCE HEALTH LTD (ASX), KELFRED (HKEx), RESPIRI LTD (ASX), OVENTUS MEDICAL LTD (ASX), Yunnan Energy (SGX), MICRO-X LTD (ASX), LBT INNOVATIONS LTD (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), METALICITY LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), USCOM LTD (ASX), LIFE HEALTHCARE (HKEx), XTANT MEDICAL HLDGS INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), RA MEDICAL SYSTEMS INC (NYSE), OPTISCAN IMAGING (ASX), CARDIEX LTD (ASX), Annica (SGX), ADHERIUM LIMITED (ASX), ANALYTICA (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DORSAVI LTD (ASX), HUAKANG BIOMED (HKEx), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --10.240
-32.31 %
10 Days -+6.150
+40.20 %
20 Days -+9.420
+78.30 %
Medium Term Return 3 Months -+13.010
+154.15 %
6 Months -+18.310
+583.12 %
1 Year -+18.470
+619.80 %
Long Term Return 2 Years -+16.990
+380.94 %
3 Years -+13.730
+177.85 %
5 Years -+13.850
+182.24 %
Annualised Return Annualised --
+23.06 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.915 - 33.790 Change From 1 Year Low +19.535 % Change From 1 Year Low (%) +1020.10
Change From 1 Year High -12.340 % Change From 1 Year High (%) -36.52
2 Years Range 1.915 - 33.790 Change From 2 Years Low +19.535 % Change From 2 Years Low (%) +1020.10
Change From 2 Years High -12.340 % Change From 2 Years High (%) -36.52
5 Years Range 1.915 - 33.790 Change From 5 Years Low +19.535 % Change From 5 Years Low (%) +1020.10
Change From 5 Years High -12.340 % Change From 5 Years High (%) -36.52
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Historical Price Data

Date Open High Low Close Volume VWAP
02 Jul 2020 19.910 22.480 19.900 21.450 52,386,860 -
01 Jul 2020 22.750 24.270 18.350 19.730 103,303,500 -
30 Jun 2020 27.040 30.000 23.590 26.950 98,019,550 -
29 Jun 2020 28.320 31.710 26.600 31.690 52,698,280 -
26 Jun 2020 31.640 33.790 24.600 29.980 149,856,400 -
25 Jun 2020 25.790 31.570 25.340 31.250 141,080,500 -
24 Jun 2020 22.120 25.600 20.630 23.870 124,818,600 -
23 Jun 2020 16.760 22.680 16.010 21.570 171,547,500 -
22 Jun 2020 14.500 15.320 14.402 15.300 16,013,700 -
19 Jun 2020 14.430 14.740 14.110 14.270 17,934,150 -
18 Jun 2020 13.670 14.500 13.610 14.340 10,916,190 -
17 Jun 2020 13.694 14.190 13.470 13.820 12,077,830 -
16 Jun 2020 14.230 14.290 13.260 13.900 13,883,370 -
15 Jun 2020 13.150 14.185 13.150 14.150 20,310,900 -
12 Jun 2020 12.610 13.400 12.550 13.020 13,115,930 -
11 Jun 2020 12.920 13.350 12.020 12.180 14,441,420 -
10 Jun 2020 13.100 13.630 12.950 13.390 15,213,580 -
09 Jun 2020 12.000 13.200 11.900 12.760 19,008,990 -
08 Jun 2020 11.850 12.100 11.130 12.030 14,861,570 -
05 Jun 2020 12.110 12.320 11.260 11.930 18,703,570 -
04 Jun 2020 12.445 12.885 11.730 11.880 18,478,100 -
03 Jun 2020 13.900 14.320 12.100 12.430 37,715,170 -
Summary
Current 2 Weeks
(19 Jun 2020 to 02 Jul 2020)
14.430 33.790 14.110 21.450 927,659,040 -
Previous 2 Weeks
(05 Jun 2020 to 18 Jun 2020)
12.110 33.790 11.260 14.340 152,533,350 -
4 Weeks from
(07 May 2020 to 04 Jun 2020)
10.420 33.790 10.150 11.880 580,004,970 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.